Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Exogenous hormones and colorectal cancer risk in Canada: associations stratified by clinically defined familial risk of cancer.

Campbell PT, Newcomb P, Gallinger S, Cotterchio M, McLaughlin JR.

Cancer Causes Control. 2007 Sep;18(7):723-33. Epub 2007 Jun 5.

PMID:
17549595
2.

Oral contraceptive use and risk of colorectal cancer.

Fernandez E, La Vecchia C, Franceschi S, Braga C, Talamini R, Negri E, Parazzini F.

Epidemiology. 1998 May;9(3):295-300.

PMID:
9583422
3.

Colorectal cancer risk associated with hormone use varies by expression of estrogen receptor-β.

Rudolph A, Toth C, Hoffmeister M, Roth W, Herpel E, Schirmacher P, Brenner H, Chang-Claude J.

Cancer Res. 2013 Jun 1;73(11):3306-15. doi: 10.1158/0008-5472.CAN-12-4051. Epub 2013 Apr 12.

4.

Reproductive history and risk of colorectal cancer in postmenopausal women.

Zervoudakis A, Strickler HD, Park Y, Xue X, Hollenbeck A, Schatzkin A, Gunter MJ.

J Natl Cancer Inst. 2011 May 18;103(10):826-34. doi: 10.1093/jnci/djr101. Epub 2011 Mar 29.

5.

Breast cancer among young U.S. women in relation to oral contraceptive use.

White E, Malone KE, Weiss NS, Daling JR.

J Natl Cancer Inst. 1994 Apr 6;86(7):505-14.

PMID:
8133534
6.

Interactions of familial and hormonal risk factors for large bowel cancer in women.

Newcomb PA, Taylor JO, Trentham-Dietz A.

Int J Epidemiol. 1999 Aug;28(4):603-8.

PMID:
10480684
7.

Hormone replacement therapy and risk of colon and rectal cancer.

Fernandez E, La Vecchia C, Braga C, Talamini R, Negri E, Parazzini F, Franceschi S.

Cancer Epidemiol Biomarkers Prev. 1998 Apr;7(4):329-33.

8.

Estrogen plus progestin use, microsatellite instability, and the risk of colorectal cancer in women.

Newcomb PA, Zheng Y, Chia VM, Morimoto LM, Doria-Rose VP, Templeton A, Thibodeau SN, Potter JD.

Cancer Res. 2007 Aug 1;67(15):7534-9.

9.

Hormone replacement therapy, oral contraceptive use, and distal large bowel cancer: a population-based case-control study.

Long MD, Martin CF, Galanko JA, Sandler RS.

Am J Gastroenterol. 2010 Aug;105(8):1843-50. doi: 10.1038/ajg.2010.123. Epub 2010 Mar 30.

10.

Reproductive factors, exogenous female hormones, and colorectal cancer by subsite.

Gerhardsson de Verdier M, London S.

Cancer Causes Control. 1992 Jul;3(4):355-60.

PMID:
1617123
11.

Excess body weight and colorectal cancer risk in Canada: associations in subgroups of clinically defined familial risk of cancer.

Campbell PT, Cotterchio M, Dicks E, Parfrey P, Gallinger S, McLaughlin JR.

Cancer Epidemiol Biomarkers Prev. 2007 Sep;16(9):1735-44.

12.

Case-control study of endogenous steroid hormones and endometrial cancer.

Potischman N, Hoover RN, Brinton LA, Siiteri P, Dorgan JF, Swanson CA, Berman ML, Mortel R, Twiggs LB, Barrett RJ, Wilbanks GD, Persky V, Lurain JR.

J Natl Cancer Inst. 1996 Aug 21;88(16):1127-35.

PMID:
8757192
13.

Do factors related to endogenous and exogenous estrogens modify the relationship between obesity and risk of colorectal adenomas in women?

Wolf LA, Terry PD, Potter JD, Bostick RM.

Cancer Epidemiol Biomarkers Prev. 2007 Apr;16(4):676-83.

14.

Reproductive factors, exogenous female hormone use and colorectal cancer risk: the Japan Public Health Center-based Prospective Study.

Akhter M, Inoue M, Kurahashi N, Iwasaki M, Sasazuki S, Tsugane S; JPHC Study Group..

Eur J Cancer Prev. 2008 Nov;17(6):515-24. doi: 10.1097/CEJ.0b013e3282f521f8.

PMID:
18941373
15.

Hormonal and reproductive influences and risk of melanoma in women.

Smith MA, Fine JA, Barnhill RL, Berwick M.

Int J Epidemiol. 1998 Oct;27(5):751-7.

PMID:
9839729
16.
17.
18.

Oral contraceptive use, reproductive factors, and colorectal cancer risk: findings from Wisconsin.

Nichols HB, Trentham-Dietz A, Hampton JM, Newcomb PA.

Cancer Epidemiol Biomarkers Prev. 2005 May;14(5):1212-8.

19.

Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.

Tworoger SS, Missmer SA, Barbieri RL, Willett WC, Colditz GA, Hankinson SE.

J Natl Cancer Inst. 2005 Apr 20;97(8):595-602.

PMID:
15840882
20.

Modification of menopausal hormone therapy-associated colorectal cancer risk by polymorphisms in sex steroid signaling, metabolism and transport related genes.

Rudolph A, Sainz J, Hein R, Hoffmeister M, Frank B, Försti A, Brenner H, Hemminki K, Chang-Claude J.

Endocr Relat Cancer. 2011 Jun 8;18(3):371-84. doi: 10.1530/ERC-11-0057. Print 2011 Jun.

Supplemental Content

Support Center